+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Tendonitis Treatment Market Size, Share & Industry Trends Analysis Report By Type (Therapy and Surgery), By Therapy Type (Physical Therapy, Hot & Cold Therapy and Shockwave Therapy), By Condition, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 91 Pages
  • November 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5709575
The Asia Pacific Tendonitis Treatment Market should witness market growth of 4.4% CAGR during the forecast period (2022-2028).

Plans for physical therapy may include ultrasound sessions to relax tendons and muscles and enhance circulation to hasten the healing process. To avoid reinjuring the injured tendon, activity should be gradually resumed and discontinued at the first sign of pain. An early return to activity or foregoing tendonitis therapy might lead to chronic overuse tendinopathy and/or ruptured tendons.

Although tendonitis can be uncomfortable, and painful, and restrict people from engaging in activities, treatment is frequently straightforward. It begins with an effort to lessen pain and inflammation. First, the sports medicine specialist will advise resting and using anti-inflammatory lotions and/or over-the-counter anti-inflammatory drugs. Additionally, if the injury is recent or serious, it is advised to adopt the RICE orthopedic injury treatment.

Along with this, in India, obesity, and overweight are growing health issues. According to the National Family Health Survey India-3 (NFHS-3), in 2005-2006, 9% of men and 13% of women between the ages of 15 and 49 were overweight or obese. The prevalence of obesity was lower among those who worked in agriculture or manual labor and higher in urban than rural areas. This rate is expected to grow even more with continuous urbanization.

The China market dominated the Asia Pacific Tendonitis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $17,134.7 million by 2028. The Japan market is estimated to grow a CAGR of 3.8% during (2022-2028). Additionally, The India market would experience a CAGR of 5.2% during (2022-2028).

Based on Type, the market is segmented into Therapy and Surgery. Based on Therapy Type, the market is segmented into Physical Therapy, Hot & Cold Therapy and Shockwave Therapy. Based on Condition, the market is segmented into Achilles Tendonitis, Jumper’s Knee, Tennis Elbow, Pitcher’s Elbow, Swimmer’s Shoulder and Golfer’s Elbow. Based on countries, the market is segmented into China, Japan, India, Australia, South Korea, Singapore, and Rest of Asia Pacific.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck & Co., Inc., Bayer AG, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Pfizer, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., and Almatica Pharma, Inc.

Scope of the Study

By Type

  • Therapy
    • Physical Therapy
    • Hot & Cold Therapy
    • Shockwave Therapy
  • Surgery

By Condition

  • Achilles Tendonitis
  • Jumper’s Knee
  • Tennis Elbow
  • Pitcher’s Elbow
  • Swimmer’s Shoulder
  • Golfer’s Elbow

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Merck & Co., Inc.
  • Bayer AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Almatica Pharma, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Tendonitis Treatment Market, by Type
1.4.2 Asia Pacific Tendonitis Treatment Market, by Condition
1.4.3 Asia Pacific Tendonitis Treatment Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies Deployed in Tendonitis Treatment Market
Chapter 4. Asia Pacific Tendonitis Treatment Market by Type
4.1 Asia Pacific Therapy Market by Country
4.2 Asia Pacific Tendonitis Treatment Market by Therapy Type
4.2.1 Asia Pacific Physical Therapy Market by Country
4.2.2 Asia Pacific Hot & Cold Therapy Market by Country
4.2.3 Asia Pacific Shockwave Therapy Market by Country
4.3 Asia Pacific Surgery Market by Country
Chapter 5. Asia Pacific Tendonitis Treatment Market by Condition
5.1 Asia Pacific Achilles Tendonitis Market by Country
5.2 Asia Pacific Jumper’s Knee Market by Country
5.3 Asia Pacific Tennis Elbow Market by Country
5.4 Asia Pacific Pitcher’s Elbow Market by Country
5.5 Asia Pacific Swimmer’s Shoulder Market by Country
5.6 Asia Pacific Golfer’s Elbow Market by Country
Chapter 6. Asia Pacific Tendonitis Treatment Market by Country
6.1 China Tendonitis Treatment Market
6.1.1 China Tendonitis Treatment Market by Type
6.1.1.1 China Tendonitis Treatment Market by Therapy Type
6.1.2 China Tendonitis Treatment Market by Condition
6.2 Japan Tendonitis Treatment Market
6.2.1 Japan Tendonitis Treatment Market by Type
6.2.1.1 Japan Tendonitis Treatment Market by Therapy Type
6.2.2 Japan Tendonitis Treatment Market by Condition
6.3 India Tendonitis Treatment Market
6.3.1 India Tendonitis Treatment Market by Type
6.3.1.1 India Tendonitis Treatment Market by Therapy Type
6.3.2 India Tendonitis Treatment Market by Condition
6.4 Australia Tendonitis Treatment Market
6.4.1 Australia Tendonitis Treatment Market by Type
6.4.1.1 Australia Tendonitis Treatment Market by Therapy Type
6.4.2 Australia Tendonitis Treatment Market by Condition
6.5 South Korea Tendonitis Treatment Market
6.5.1 South Korea Tendonitis Treatment Market by Type
6.5.1.1 South Korea Tendonitis Treatment Market by Therapy Type
6.5.2 South Korea Tendonitis Treatment Market by Condition
6.6 Singapore Tendonitis Treatment Market
6.6.1 Singapore Tendonitis Treatment Market by Type
6.6.1.1 Singapore Tendonitis Treatment Market by Therapy Type
6.6.2 Singapore Tendonitis Treatment Market by Condition
6.7 Rest of Asia Pacific Tendonitis Treatment Market
6.7.1 Rest of Asia Pacific Tendonitis Treatment Market by Type
6.7.1.1 Rest of Asia Pacific Tendonitis Treatment Market by Therapy Type
6.7.2 Rest of Asia Pacific Tendonitis Treatment Market by Condition
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent Strategies and Developments
7.1.5.1 Approvals and Trials
7.1.6 SWOT Analysis
7.2 AstraZeneca PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments
7.2.5.1 Acquisition and Mergers
7.3 GlaxoSmithKline PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent Strategies and Developments
7.3.5.1 Acquisitions and Mergers
7.4 Merck & Co., Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Acquisition and Mergers
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations, and Agreements
7.6 Boehringer Ingelheim International Gmbh
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional & Segmental Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent Strategies and Developments
7.6.5.1 Product Launches and Product Expansions
7.6.5.2 Acquisition and Mergers
7.7 Bayer AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent Strategies and Developments
7.8.5.1 Acquisition and Mergers
7.9 Almatica Pharma LLC (Alvogen, Inc.)
7.9.1 Company Overview

Companies Mentioned

  • Merck & Co., Inc.
  • Bayer AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Almatica Pharma, Inc.

Methodology

Loading
LOADING...